Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

NIH launches deep dive into gulf war illness mystery

NCT ID NCT05375812

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 10 times

Summary

This study aims to understand Gulf War Illness (GWI), a condition affecting up to 210,000 veterans with symptoms like fatigue, pain, and memory problems. Researchers will compare 85 Gulf War veterans—some with GWI and some without—through extensive tests including blood draws, scans, sleep studies, and surveys during a two-week inpatient stay. The goal is to identify biological and clinical differences that could explain the illness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study succeeds, it could reveal biological markers or mechanisms underlying Gulf War Illness, pointing toward future diagnostic tools or treatments.
What could go wrong
This is an observational study, not a treatment trial. It may not find clear differences between groups, and findings may not directly lead to therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 85 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2023

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

A Target of 50 GWI participants and 25 Healthy volunteer controls will be selected.

Ages

48 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: Inclusion criteria for all veterans: * Ability to provide informed consent * Stated willingness to comply with all study procedures and availability for the duration of the study * Age 48-70 at time of enrollment into VA IN-DEPTH Study * Veterans who were deployed to Gulf Region ODS/S between August 1990 - June 1991. * Self-reported completion of at least the seventh grade of school. * Fluency in speaking, reading, and understanding English. * Underwent screening as part of the VA IN-DEPTH study and were unanimously determined to be eligible by the IN-DEPTH Adjudication Committee. * Agree not to smoke in the 4 hours prior to CPET procedure EXCLUSION CRITERIA: Exclusion criteria for all veterans: * Current or past psychotic disorder including depression with psychosis, bipolar disorder with psychotic symptoms and schizophrenia * Current DSM-5-defined major depression disorder, generalized anxiety disorder, posttraumatic stress disorder, panic disorder, or obsessive-compulsive disorder unless managed for more than six months with a stable treatment regimen * Current or past substance use disorder within last five years as diagnosed on the Structured Clinical Interview for DSM-5 (SCID-5). Prior or prescription marijuana use within the past five years will not be an exclusion. * Current suicidal ideation * History of head injury leading to moderate or severe traumatic brain injury, as detailed by loss of consciousness for greater than 30 minutes, a Glasgow Coma Score of 12 or less at the time of injury, post-traumatic amnesia greater than one day, or brain-scan changes related to a head injury. Persons having a history of mild TBI (mTBI) will not be excluded. * Women who are pregnant, breastfeeding, or are within one-year post-partum. * Current or previous malignancy. A history of malignancy that has fully resolved with surgical resection only (e.g. no chemotherapy, radiation therapy, or immunotherapy) will be allowed. * Current systemic immunologic disorders (e.g. Type 1 diabetes, rheumatoid arthritis). Local immunological disorder (e.g. atopic dermatitis, stable autoimmune thyroid disease) and allergic disorders will be allowed. * Current or previous long-term immune suppressive therapy. Systemic steroid use, even short-term, must not have been used within the month prior to enrollment * Any medical condition that would make the study procedures risky for the participant (e.g. congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, severe osteoarthritis, exercise-induced angina and poorly controlled asthma). * Active participation in a clinical protocol (e.g. anti-inflammatory drug intervention study) which includes an intervention that may affect the results of the current study. * Inability to perform the bicycling exercise task. (e.g. coronary artery disease, not having a lower limb, disabling stroke) * Not willing to allow for research data and samples to be shared broadly with other researchers. * Symptom severity that makes it impossible for the volunteer to travel to NIH for extended inpatient evaluation * Use of medications with a high-risk for withdrawal-related complications (i.e. long-acting opiates or benzodiazepines). Additional Exclusion criteria for participants undergoing TMS: \- Pacemaker, implanted pump, stimulator, cochlear implant or metal objects inside the eye or skull. Participants with unconfirmed metal may have further evaluation to rule out metal in the eye or skull. Participants without metal after evaluation may proceed to TMS. \- A personal history of seizure disorder Additional Exclusion criteria for participants undergoing MRI: \- Metal in the body which would make having an MRI scan unsafe, such as pacemakers, stimulators, pumps, aneurysm clips, metallic prostheses, artificial heart valves, cochlear implants or shrapnel fragments, or having a history of being a welder or metal worker, since small metal fragments may be in the eye. Participants with unconfirmed metal may have further evaluation to rule out metal in the eye or skull. Participants without metal after evaluation may proceed to MRI. * Substantial claustrophobia * Inability to lie on back for up to 2 hours Additional Exclusion criteria for Healthy Veteran Controls: \- Meets modified Kansas criteria for GWI.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gulf war illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.